Skip to content

Multi-Center, Randomized Trial of the Pulsed Dye Laser for JORRP

A Multi-Center, Randomized, Controlled Trial of the Pulsed Dye Laser for Juvenile Onset Recurrent Respiratory Papillomatosis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00550914
Enrollment
34
Registered
2007-10-30
Start date
2007-01-31
Completion date
2009-06-30
Last updated
2010-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent Respiratory Papillomatosis

Keywords

Papilloma, Papillomatosis, Laser, Laser Surgery

Brief summary

The purpose of this study is to determine whether the 585-nm pulse dye laser can decrease the time interval between surgeries and improve voice outcomes in children with severe RRP.

Interventions

None listed

Sponsors

Rady Children's Hospital, San Diego
CollaboratorOTHER
Massachusetts Eye and Ear Infirmary
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

1. Immunocompetent children ages 1-12 with symptomatic JORRP requiring operative intervention 2. Children who have historically required at least four surgeries in the year preceding enrollment to treat laryngeal JORRP

Exclusion criteria

1. Children who have required fewer than four procedures to treat laryngeal JORRP in the year prior to enrollment. 2. Children who are currently receiving adjuvant therapies for JORRP including cidofovir, interferon, indole-3-carbinol or Hsp-E7. 3. Caregivers who are non-English speaking as the PVRQOL instrument has been validated only in the English language. 4. Children whose families do not sign an informed consent to enter into the study. 5. Children whose families anticipate discontinuing care at a participating institution during the study period

Design outcomes

Primary

MeasureTime frame
Measure: Time interval between surgical therapy for recurrent respiratory papillomatosisOne Year

Secondary

MeasureTime frame
Measure: Validated voice questionnaire and intraoperative laryngoscopic staging scoreOne Year

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026